Phillip James Consulting’s Amgen AMGN Stock Holding History

Phillip James Consulting’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.81K	Hold	5	–	–	﹤0.01%	224
2026 Q1	$1K	Buy	+5	New	+$1.78K	﹤0.01%	254

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Phillip James Consulting's AMGN Position: Q2 2026 in Review

Phillip James Consulting held its Amgen (AMGN) position steady in Q2 2026 at 5 shares worth $1.81K. The position accounts for ﹤0.01% of the portfolio, ranked #224.

Phillip James Consulting first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Phillip James Consulting held 5 shares of Amgen worth $1.81K as of Q2 2026.
Phillip James Consulting left its Amgen share count unchanged in Q2 2026.
Amgen made up ﹤0.01% of Phillip James Consulting's portfolio in Q2 2026, its #224 holding.
Phillip James Consulting first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
3,137 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Phillip James Consulting's 13F filing for Q2 2026, filed 28 Jul 2026.